Clinical Trials Logo

Clinical Trial Summary

This protocol for SUN-131 1.5% TDS is developed for the treatment of chalazion. SUN-131 1.5% TDS is designed for local delivery of a corticosteroid, to the upper or lower eyelid. The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared with placebo TDS in the treatment of a chalazion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03248440
Study type Interventional
Source Senju USA, Inc.
Contact
Status Completed
Phase Phase 3
Start date July 31, 2017
Completion date August 17, 2018

See also
  Status Clinical Trial Phase
Completed NCT01202747 - Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction Phase 2/Phase 3
Completed NCT02338648 - Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion Phase 2
Completed NCT00420628 - Pediatric Zylet Safety and Efficacy Study Phase 4
Withdrawn NCT01763437 - Intralesional Tetracycline Injection in the Treatment of Chalazia Phase 0
Recruiting NCT05070611 - Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia N/A
Completed NCT00832130 - Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye N/A
Completed NCT04322500 - Probiotics for Chalaziosis Treatment in Children N/A
Completed NCT04342507 - Probiotics for Treatment of Chalazion in Adults N/A
Recruiting NCT02025023 - Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study Phase 3
Recruiting NCT05512572 - Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion N/A